Login Start free

Focus

Drug Development Investors: Angels and VC Firms

The RaiseHunt database lists 92 Drug Development investors: 54 angel investors and 38 people at 10 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.

Strongest in New York, San Francisco and Boston

Common stages: Seed and Series A

92: Drug Development investors
54: Angel investors
38: People at VC/PE firms
10: Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

92 Drug Development investors

Showing 21-40

Filters

Viewing

Drug Development92

Investor Type

Choosing one replaces Drug Development.

Investment Stage

Choosing one replaces Drug Development.

Seed84,745
Series A53,997
Late-Stage37,937
Series B35,865
Growth34,738
Pre-Seed32,477

Investment Profile

Choosing one replaces Drug Development.

SaaS63,483
FinTech54,183
Healthcare53,462
Consumer46,735
AI46,189
Hardware36,507
Commerce32,773
Climate23,313
Real Estate17,905
Education13,608
Food10,848
Travel7,450
Energy946
Agriculture555

Country

Choosing one replaces Drug Development.

City

Choosing one replaces Drug Development.

Focus1

Investor	Location	Type	Markets	Contact	Actions
Michael Schorpp Investor at Boehringer Ingelheim	Biberach an der Riß, Germany	Corporate VC	AIHealthcare		View profile
Anthony Lawrence angel investor	Singapore	Angel	ConsumerHealthcare		View profile
Jason Curry angel investor and operator angel	Pittsburgh, United States	AngelOperator angel	FinTechHealthcare		View profile
Brandon Drew angel investor and operator angel	Smyrna, United States	AngelOperator angel	HardwareHealthcare		View profile
Fabrice Chouraqui angel investor and operator angel	United States	AngelOperator angel	Healthcare		View profile
Cindy Xiong Partner at Foresite Capital	San Diego, United States	Venture capital	AIHealthcare		View profile
Mera Tilley angel investor	Boston, United States	Angel	Healthcare		View profile
Michael Rome Managing Director at Foresite Capital	Los Angeles, United States	Venture capital	AIHealthcare		View profile
Luke Bagaason Director at Foresite Capital	Denver, United States	Venture capital	AIHealthcare		View profile
Martin Blüggel angel investor and operator angel	Dortmund, Germany	AngelOperator angel	AIHealthcare		View profile
Celine Halioua angel investor and operator angel	San Francisco, United States	AngelOperator angel	Healthcare		View profile
JS Jeff Szekeres Senior Vice President at Danaher	Solana Beach, United States	Angel	Healthcare		View profile
DW David Walt Hansjörg Wyss Professor of Biologically Inspired Engineering at HMS MEDscience	Boston, United States	AngelOperator angel	AIHealthcare		View profile
EG Easha Ghildyal Vice President at Prescient	London, United Kingdom	Angel	AIHealthcare		View profile
UV Umang Vohra Investor at Cipla	Mumbai, India	Angel	EducationHealthcare		View profile
JR John Rex Consultant and Operating Partner at Advent Life Sciences	Wellesley Hills, United States	Angel	Healthcare		View profile
JR Jonathan Ross Goodman Executive Chair at Knight Therapeutics	Montreal, Canada	AngelOperator angel	ConsumerFood		View profile
JA Jeffrey Aronin Chairman and CEO at Paragon Biosciences	United States	AngelOperator angel	Healthcare		View profile
OR Oliver Reuss Executive Director / Investment Manager at Boehringer Ingelheim	Germany	Corporate VC	AIHealthcare		View profile
SB Steve Boren Investor at Boehringer Ingelheim	Duluth, United States	Corporate VC	AIHealthcare		View profile

Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal